Skip to main content
. 2012 Aug 15;2012(8):CD004643. doi: 10.1002/14651858.CD004643.pub3

Comparison 1. Doxazosin vs Placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Change in trough SBP 2   Mean Difference (IV, Fixed, 95% CI) Subtotals only
1.1 2 mg 2 93 Mean Difference (IV, Fixed, 95% CI) ‐5.03 [‐10.71, 0.64]
1.2 4 mg 2 91 Mean Difference (IV, Fixed, 95% CI) ‐5.84 [‐11.44, ‐0.23]
1.3 8 mg 2 91 Mean Difference (IV, Fixed, 95% CI) ‐7.24 [‐12.93, ‐1.56]
1.4 12 mg 1 55 Mean Difference (IV, Fixed, 95% CI) ‐6.1 [‐15.27, 3.07]
2 Change in trough DBP 3   Mean Difference (IV, Fixed, 95% CI) Subtotals only
2.1 2 mg 2 93 Mean Difference (IV, Fixed, 95% CI) ‐3.01 [‐6.43, 0.42]
2.2 4 mg 3 326 Mean Difference (IV, Fixed, 95% CI) ‐3.36 [‐5.06, ‐1.66]
2.3 8 mg 2 90 Mean Difference (IV, Fixed, 95% CI) ‐4.13 [‐7.61, ‐0.65]
2.4 12 mg 1 56 Mean Difference (IV, Fixed, 95% CI) ‐3.8 [‐8.64, 1.04]
3 Change in peak SBP 1   Mean Difference (IV, Fixed, 95% CI) Subtotals only
3.1 2 mg 1 44 Mean Difference (IV, Fixed, 95% CI) ‐6.8 [‐13.96, 0.36]
3.2 4 mg 1 35 Mean Difference (IV, Fixed, 95% CI) ‐6.0 [‐13.08, 1.08]
3.3 8 mg 1 35 Mean Difference (IV, Fixed, 95% CI) ‐12.90 [‐20.34, ‐5.46]
4 Change in peak DBP 1   Mean Difference (IV, Fixed, 95% CI) Subtotals only
4.1 2 mg 1 44 Mean Difference (IV, Fixed, 95% CI) ‐4.30 [‐8.92, 0.32]
4.2 4 mg 1 35 Mean Difference (IV, Fixed, 95% CI) ‐4.4 [‐9.02, 0.22]
4.3 8 mg 1 35 Mean Difference (IV, Fixed, 95% CI) ‐8.5 [‐13.32, ‐3.68]
5 Change in trough heart rate 1   Mean Difference (IV, Fixed, 95% CI) Subtotals only
5.1 2 mg 1 44 Mean Difference (IV, Fixed, 95% CI) ‐1.90 [‐6.62, 2.82]
5.2 4 mg 1 35 Mean Difference (IV, Fixed, 95% CI) ‐1.5 [‐6.22, 3.22]
5.3 8 mg 1 35 Mean Difference (IV, Fixed, 95% CI) 1.0 [‐4.67, 6.67]
6 Change in peak heart rate 1   Mean Difference (IV, Fixed, 95% CI) Subtotals only
6.1 2 mg 1 44 Mean Difference (IV, Fixed, 95% CI) ‐0.10 [‐4.82, 4.62]
6.2 4 mg 1 35 Mean Difference (IV, Fixed, 95% CI) 1.30 [‐3.42, 6.02]
6.3 8 mg 1 35 Mean Difference (IV, Fixed, 95% CI) 3.2 [‐2.47, 8.87]
7 Total withdrawals due to adverse effects 2   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
7.1 2‐8 mg 1 135 Risk Ratio (M‐H, Fixed, 95% CI) 1.94 [0.24, 15.54]
7.2 2‐12 mg 1 248 Risk Ratio (M‐H, Fixed, 95% CI) 2.71 [0.66, 11.13]